MedPath

Cytora Ltd.

Cytora Ltd. logo
🇬🇧United Kingdom
Ownership
Holding
Established
2014-01-01
Employees
51
Market Cap
-
Website
http://www.cytora.com

Clinical Trials

2

Active:2
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200

Phase 1
Active, not recruiting
Conditions
Diabetic Foot Ulcer
Diabetic Foot Ulcer Neuropathic
Diabetic Foot
First Posted Date
2023-08-22
Last Posted Date
2024-03-13
Lead Sponsor
Cytora Ltd.
Target Recruit Count
21
Registration Number
NCT06003530
Locations
🇮🇱

Shaare Zedek Medical Center, Jerusalem, Israel

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)

Phase 1
Active, not recruiting
Conditions
Multiple System Atrophy
MSA - Multiple System Atrophy
Interventions
First Posted Date
2023-01-26
Last Posted Date
2025-01-29
Lead Sponsor
Cytora Ltd.
Target Recruit Count
10
Registration Number
NCT05698017
Locations
🇮🇱

Tel-Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.